VIA Pharmaceuticals receives favorable hearing decision from Nasdaq
The NASDAQ Hearing Panel has granted the company's request to remain listed on NASDAQ, subject to the company demonstrating compliance with the NASDAQ Listing Rules on or before December 31. :theflyonthewall.com
News For VIAP From The Last 14 Days
Check below for free stories on VIAP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
